Triglycerides and coronary heart disease: A global perspective

Journal of Cardiovascular Risk

Volumn 7, Issue 5, 2000, Pages 303-307

  Ahmad, I ^a   Miller, M ^a  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

Cholesterol; Coronary heart disease; Populations; Triglycerides

Indexed keywords

FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; REVIEW;

EID: 84910155963     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1177/204748730000700502     Document Type: Review

References (41)

1. Coronary heart disease in seven countries
2. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
3. Plasma triglyceride level and mortality from coronary heart disease
4. Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease
5. Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
6. Relation of high triglyceride-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease: An 8-year follow-up in the Copenhagen Male Study
7. The epidemiology of triglyceride as a coronary artery disease risk factor
8. Elevated serum triglyceride levels and tong-term mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Registry
9. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
10. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
11. The importance of triglycerides: Results from the Prospective Cardiovascular Munster (PROCAM) Study
12. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study
13. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The Bezafibrate Infarction Prevention (BIP) Study
14. Trends in cardiovascular mortality in industrialized countries since 1950
15. Triglyceride levels and the risk of coronary artery disease: A view from Australia
16. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults
17. Concentration of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease
18. Is the level of serum triglyceride a significant predictor of coronary death in 'normocholesterolemic' subjects: The Paris Prospective Study
19. Ten-year follow-up results from the Goettingen risk, incidence and prevalence study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men
20. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
21. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: The Bezafibrate Infarction Prevention (BIP) Registry
22. Multivariate prediction of coronary deaths in a 10 year follow-up of an Italian occupational cohort
23. Relation of waist-hip ratio to glucose tolerance, blood pressure, and serum lipids in middle-aged Japanese males
24. Concomitants of excess coronary deaths - Major risk factors and lifestyle findings rrom 10 359 men and women in the Scottish Heart Health Study
25. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence
26. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris: Results from a 10-year follow-up of Upsala Primary Preventive Study
27. The Pathogenesis of Atherosclerosis. Collaborative US-USSR study on the prevalence of dyslipoproteinemias and ischemic heart disease in American and Soviet populations
28. Do triglycerides provide meaningful information about heart disease risk?
29. Coronary artery disease in Asian Indians: Prevalence and risk factors
30. Prevalence of coronary artery disease in Asian-Indians
31. Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian Indians
32. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
33. Erythrocyte fatty acids, plasma lipids, and cardiovascular disease in rural China
34. Body-mass index and mortality in a prospective cohort of U.S. adults
35. Declining serum total cholesterol levels among US adults: The National Health and Nutrition Examination Surveys
36. Impaired fasting glucose, lipid levels and prevalence of coronary heart disease
37. The impending global epidemic of cardiovascular diseases
38. The study of health assessment and risk in ethnic groups (SHARE): Rationale and design
39. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada
40. Underutilization of lipid lowering therapy in patients with coronary disease